ERAMET Valuation

Is ERAP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ERAP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ERAP (€51.05) is trading above our estimate of fair value (€48.92)

Significantly Below Fair Value: ERAP is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ERAP?

Key metric: As ERAP is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ERAP. This is calculated by dividing ERAP's market cap by their current revenue.
What is ERAP's PS Ratio?
PS Ratio0.4x
Sales€3.20b
Market Cap€1.43b

Price to Sales Ratio vs Peers

How does ERAP's PS Ratio compare to its peers?

The above table shows the PS ratio for ERAP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.1x
KMR Kenmare Resources
1.1x5.6%UK£321.2m
GFM Griffin Mining
2x-5.1%UK£260.3m
CAPD Capital
0.6x3.0%UK£164.5m
MTL Metals Exploration
0.7x-5.7%UK£98.5m
ERAP ERAMET
0.4x7.9%€1.4b

Price-To-Sales vs Peers: ERAP is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (1.1x).


Price to Sales Ratio vs Industry

How does ERAP's PS Ratio compare vs other companies in the GB Metals and Mining Industry?

14 CompaniesPrice / SalesEstimated GrowthMarket Cap
GLEN Glencore
0.3x-0.8%US$58.65b
NLMK Novolipetsk Steel
0.3xn/aUS$4.08b
EVR EVRAZ
0.1x-8.5%US$1.42b
PDL Petra Diamonds
0.2x8.5%US$83.83m
No. of Companies14PS01.22.43.64.86+
14 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ERAP is good value based on its Price-To-Sales Ratio (0.4x) compared to the UK Metals and Mining industry average (2x).


Price to Sales Ratio vs Fair Ratio

What is ERAP's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ERAP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate ERAP's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ERAP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€50.53
€88.80
+75.8%
40.0%€148.00€45.00n/a5
Nov ’25€54.00
€94.60
+75.2%
39.2%€148.00€45.00n/a5
Oct ’25€70.73
€125.20
+77.0%
22.6%€150.00€72.00n/a5
Sep ’25n/a
€152.80
0%
16.6%€184.00€107.00n/a5
Aug ’25€82.73
€152.80
+84.7%
16.6%€184.00€107.00n/a5
Jul ’25n/a
€151.40
0%
16.4%€183.00€107.00n/a5
Jun ’25€102.60
€134.40
+31.0%
26.1%€172.00€73.00n/a5
May ’25n/a
€118.80
0%
31.1%€172.00€73.00n/a5
Apr ’25n/a
€111.60
0%
29.8%€161.00€73.00n/a5
Mar ’25n/a
€114.20
0%
26.6%€156.00€73.00n/a5
Feb ’25€65.05
€120.00
+84.5%
35.6%€192.00€73.00n/a5
Jan ’25n/a
€121.60
0%
33.9%€192.00€77.00n/a5
Dec ’24n/a
€121.60
0%
33.9%€192.00€77.00n/a5
Nov ’24€65.05
€121.60
+86.9%
28.6%€180.00€85.00€54.005
Oct ’24n/a
€127.20
0%
29.2%€192.00€91.00€70.735
Sep ’24€64.65
€126.40
+95.5%
30.0%€192.00€87.00n/a5
Aug ’24€73.50
€131.60
+79.0%
28.0%€192.00€93.00€82.735
Jul ’24n/a
€139.80
0%
20.7%€170.00€93.00n/a5
Jun ’24n/a
€146.75
0%
17.1%€170.00€110.00€102.604
May ’24n/a
€150.00
0%
18.3%€180.00€110.00n/a4
Apr ’24n/a
€145.75
0%
15.6%€170.00€110.00n/a4
Mar ’24€103.65
€145.75
+40.6%
15.6%€170.00€110.00n/a4
Feb ’24€102.70
€144.75
+40.9%
29.9%€210.00€88.00€65.054
Jan ’24n/a
€131.00
0%
38.5%€210.00€86.00n/a4
Dec ’23€79.40
€131.00
+65.0%
38.5%€210.00€86.00n/a4
Nov ’23€66.40
€131.00
+97.3%
38.5%€210.00€86.00€65.054

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies